LFCR vs PG · $207.1M cap vs P/E 25, rev $84.28B
Lifecore Biomedical Inc. (LFCR) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
LFCR does not have a complete income-statement cache yet.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
LFCR currently screens at market cap $207.1M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the LFCR and PG stock pages for the full models.
Not investment advice.